Search results
This Analyst Says Artivion's Sell Off Seems Overdone After Trial Halt
Benzinga via Yahoo Finance· 2 years agoOn Friday, Artivion Inc (NYSE: AORT) stopped the PROACT Xa clinical trial after the Data Safety...
Artivion Stock Plunges Apixaban Vs. Warfarin Trial Setback, Reaffirms Annual Guidance
Benzinga via Yahoo Finance· 2 years agoArtivion Inc (NYSE: AORT) has stopped the PROACT Xa trial to determine if patients with an On-X...
Artivion, Inc. (NYSE:AORT) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 9 months agoArtivion, Inc. (NYSE:AORT) Q2 2023 Earnings Call Transcript August 5, 2023 Operator: Greetings, and...